Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database.
PMID: 37497812 ·
C, a, i, t, l, i, n, , E, , C, a, r, l, t, o, n, ;, , C, o, l, b, y, , P, , S, o, u, d, e, r, s, ;, , N, a, t, h, a, n, , A, , C, h, e, r, t, a, c, k, ;, , R, a, m, y, , S, , G, o, u, e, l, i, ;, , G, a, r, y, , E, , L, e, m, a, c, k, ;, , J, e, n, n, i, f, e, r, , T, , A, n, g, e, r, ;, , L, y, n, n, , M, c, C, l, e, l, l, a, n, d, ;, , M, a, u, d, e, , E, , C, a, r, m, e, l
Реклама
Аннотация
Over 350 000 sacral neuromodulation (SNM) devices have been implanted since approval by the Food and Drug Administration (FDA) in 1998. SNM technology and clinical applications have evolved, with minimal safety updates after initial trials. We aim to provide an updated overview of real-world SNM safety. These insights will guide informed consent, preoperative counseling, and patient expectation-setting. The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a repository for
Реклама
Официальный источник
Открыть в PubMed →Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.